Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-22 Purchase | 2026-06-24 06:05 am | Seaport Therapeutics Inc. | SPTX | HOMBACH ROBERT J. Director | 13,000 | $18.14 | $235,768 | 13,000 (Indirect) | View |
| 2026-05-04 Purchase | 2026-05-04 6:02 pm | Seaport Therapeutics Inc. | SPTX | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 1,100,000 | $18 | $19,800,000 | 6,294,951 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2026-05-06 9:16 pm | N/A N/A | Seaport Therapeutics Inc. | SPTX | GAP Coinvestments CDA L.P. General Atlantic Partners (Lux) SCSp General Atlantic (Lux) S.a r.l. General Atlantic GenPar (Lux) SCSp Director 10% Owner | 0 | $0 | 6,101,582 (Indirect) | View |
Ownership | 2026-05-06 9:14 pm | N/A N/A | Seaport Therapeutics Inc. | SPTX | General Atlantic (SP) L.P. GENERAL ATLANTIC L.P. GENERAL ATLANTIC GENPAR L.P. General Atlantic Partners 100 L.P. GAP COINVESTMENTS III LLC GAP COINVESTMENTS IV LLC GAP Coinvestments V LLC GENERAL ATLANTIC GENPAR (BERMUDA) L.P. General Atlantic (SPV) GP LLC GAP (Bermuda) L.P. Director 10% Owner | 0 | $0 | 6,101,582 (Indirect) | View |
| 2026-05-04 Conversion | 2026-05-06 7:38 pm | N/A N/A | Seaport Therapeutics Inc. | SPTX | PureTech Health plc PureTech LYT Inc. 10% Owner | 67,835,164 | $0 | 16,685,013 (Indirect) | View |
| 2026-04-30 Option Award | 2026-05-04 6:18 pm | N/A 2036-04-29 | Seaport Therapeutics Inc. | SPTX | Zohar Daphne Chief Executive Officer | 1,758,599 | $0 | 1,758,599 (Direct) | View |
| 2026-05-04 Conversion | 2026-05-04 6:14 pm | N/A N/A | Seaport Therapeutics Inc. | SPTX | HEALY JAMES Director | 11,310,484 | $0 | 2,731,538 (Indirect) | View |
| 2026-04-30 Option Award | 2026-05-04 6:13 pm | N/A 2036-04-29 | Seaport Therapeutics Inc. | SPTX | White Lauren Chief Financial Officer | 63,680 | $0 | 70,382 (Direct) | View |
| 2026-05-04 Conversion | 2026-05-04 6:13 pm | N/A N/A | Seaport Therapeutics Inc. | SPTX | White Lauren Chief Financial Officer | 27,754 | $0 | 70,382 (Indirect) | View |
| 2026-04-30 Option Award | 2026-05-04 6:10 pm | N/A 2036-04-29 | Seaport Therapeutics Inc. | SPTX | Wheadon David E. Director | 12,258 | $0 | 12,258 (Direct) | View |
| 2026-04-30 Option Award | 2026-05-04 6:09 pm | N/A 2036-04-29 | Seaport Therapeutics Inc. | SPTX | PETERSON SANDRA E Director | 12,258 | $0 | 12,258 (Direct) | View |
| 2026-04-30 Option Award | 2026-05-04 6:08 pm | N/A 2036-04-29 | Seaport Therapeutics Inc. | SPTX | Gladstein Lana General Counsel | 63,680 | $0 | 97,195 (Direct) | View |
| 2026-05-04 Conversion | 2026-05-04 6:08 pm | N/A N/A | Seaport Therapeutics Inc. | SPTX | Gladstein Lana General Counsel | 138,778 | $0 | 97,195 (Direct) | View |
| 2026-04-30 Option Award | 2026-05-04 6:07 pm | N/A 2036-04-29 | Seaport Therapeutics Inc. | SPTX | Chen Michael Cunyuan Chief Scientific Officer | 63,680 | $0 | 67,031 (Direct) | View |
| 2026-05-04 Conversion | 2026-05-04 6:07 pm | N/A N/A | Seaport Therapeutics Inc. | SPTX | Chen Michael Cunyuan Chief Scientific Officer | 13,877 | $0 | 67,031 (Direct) | View |
| 2026-04-30 Option Award | 2026-05-04 6:06 pm | N/A 2036-04-29 | Seaport Therapeutics Inc. | SPTX | Torres Denice Director | 12,258 | $0 | 25,664 (Direct) | View |
| 2026-05-04 Conversion | 2026-05-04 6:06 pm | N/A N/A | Seaport Therapeutics Inc. | SPTX | Torres Denice Director | 55,511 | $0 | 25,664 (Indirect) | View |
| 2026-04-30 Option Award | 2026-05-04 6:05 pm | N/A 2036-04-29 | Seaport Therapeutics Inc. | SPTX | PAUL STEVEN M Director | 1,003,450 | $0 | 1,866,481 (Direct) | View |
| 2026-05-04 Conversion | 2026-05-04 6:05 pm | N/A N/A | Seaport Therapeutics Inc. | SPTX | PAUL STEVEN M Director | 277,557 | $0 | 1,866,481 (Direct) | View |
| 2026-05-04 Conversion | 2026-05-04 6:02 pm | N/A N/A | Seaport Therapeutics Inc. | SPTX | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 5,194,951 | $0 | 6,294,951 (Indirect) | View |
| 2026-04-30 Option Award | 2026-05-04 6:02 pm | N/A 2036-04-29 | Seaport Therapeutics Inc. | SPTX | HOMBACH ROBERT J. Director | 12,258 | $0 | 12,258 (Direct) | View |
| 2026-04-30 Option Award | 2026-05-04 6:01 pm | N/A 2036-04-29 | Seaport Therapeutics Inc. | SPTX | Loebel Antony Chief Medical Officer | 63,680 | $0 | 83,789 (Direct) | View |
| 2026-05-04 Conversion | 2026-05-04 6:01 pm | N/A N/A | Seaport Therapeutics Inc. | SPTX | Loebel Antony Chief Medical Officer | 83,266 | $0 | 83,789 (Direct) | View |
| 2026-04-30 Option Award | 2026-05-04 6:00 pm | N/A 2036-04-29 | Seaport Therapeutics Inc. | SPTX | Mates Sharon Director | 49,033 | $0 | 49,033 (Direct) | View |
Ownership | 2026-04-30 9:35 pm | N/A N/A | Seaport Therapeutics Inc. | SPTX | PureTech Health plc PureTech LYT Inc. 10% Owner | 0 | $0 | 16,685,013 (Indirect) | View |
Ownership | 2026-04-30 8:18 pm | N/A 2034-12-28 | Seaport Therapeutics Inc. | SPTX | PETERSON SANDRA E Director | 0 | $0 | 89,300 (Direct) | View |
Ownership | 2026-04-30 8:17 pm | N/A N/A | Seaport Therapeutics Inc. | SPTX | Zohar Daphne Chief Executive Officer | 0 | $0 | 3,959,558 (Direct) | View |
Ownership | 2026-04-30 8:14 pm | N/A N/A | Seaport Therapeutics Inc. | SPTX | Torres Denice Director | 0 | $0 | 102,706 (Indirect) | View |
Ownership | 2026-04-30 8:14 pm | N/A N/A | Seaport Therapeutics Inc. | SPTX | White Lauren Chief Financial Officer | 0 | $0 | 508,553 (Indirect) | View |
Ownership | 2026-04-30 8:10 pm | N/A 2034-08-11 | Seaport Therapeutics Inc. | SPTX | Wheadon David E. Director | 0 | $0 | 89,300 (Direct) | View |
Ownership | 2026-04-30 8:10 pm | N/A N/A | Seaport Therapeutics Inc. | SPTX | HEALY JAMES Director | 0 | $0 | 2,731,538 (Indirect) | View |
Ownership | 2026-04-30 8:09 pm | N/A N/A | Seaport Therapeutics Inc. | SPTX | PAUL STEVEN M Director | 0 | $0 | 2,537,784 (Direct) | View |
Ownership | 2026-04-30 8:09 pm | N/A N/A | Seaport Therapeutics Inc. | SPTX | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner | 0 | $0 | 5,194,951 (Indirect) | View |
Ownership | 2026-04-30 8:07 pm | N/A N/A | Seaport Therapeutics Inc. | SPTX | Gladstein Lana General Counsel | 0 | $0 | 370,488 (Direct) | View |
Ownership | 2026-04-30 8:05 pm | N/A N/A | Seaport Therapeutics Inc. | SPTX | Chen Michael Cunyuan Chief Scientific Officer | 0 | $0 | 571,958 (Direct) | View |
Ownership | 2026-04-30 8:05 pm | N/A 2035-03-02 | Seaport Therapeutics Inc. | SPTX | HOMBACH ROBERT J. Director | 0 | $0 | 89,300 (Direct) | View |
Ownership | 2026-04-30 8:04 pm | N/A N/A | Seaport Therapeutics Inc. | SPTX | Loebel Antony Chief Medical Officer | 0 | $0 | 628,388 (Direct) | View |